To strengthen the idea that H2AZ2 also regulates cell cycle genes in glioma patients, we subjected genes that positively correlated with H2AZ2 expression in gliomas to the ConsensusPathDB analysis, revealing an enrichment of the cell cycle pathway in both TCGA and REMBRANDT cohorts (Fig. 7I). The gene discussed is H2AZ2; the disease is central nervous system cancer.